Literature DB >> 9522290

Epidemiology of Klebsiella bacteraemia: a case control study using Escherichia coli bacteraemia as control.

D S Hansen1, A Gottschau, H J Kolmos.   

Abstract

Epidemiological data from 117 episodes of Klebsiella bacteraemia were compared with those from matched controls with Escherichia coli bacteraemia. Cases and controls were obtained from 20,631 blood cultures taken from patients in Hvidovre Hospital between 1990 and 1992. The data studied included: sex and age, risk factors, portal of entry, outcome, nosocomial acquisition and distribution within the hospital. The incidence of Klebsiella bacteraemia was 9.3/10,000 admissions (76% Klebsiella pneumoniae; 24% Klebsiella oxytoca). Patients with Klebsiella and E. coli bacteraemia had many common features, including a high incidence of neoplastic disease, biliary tract disease, and renal failure. Many had undergone surgery or received therapy with steroids, antacids or antibiotics. Klebsiella bacteraemia was more often found in males, in patients with hospital contact within the previous month, and polymicrobial infection. Logistic regression analysis showed that use of invasive plastic devices and diabetes were significantly associated with Klebsiella bacteraemia. The urinary tract was the commonest source, followed by the biliary tract; 27% of patients had no obvious focus of infection, and in many of these an invasive device may have been involved. Forty-five K-serotypes were found--the largest number being nine strains of type K3; only a few strains had acquired resistance characters to antimicrobial agents. There were no differences between community- and hospital-acquired strains; indicating that our hospital does not have a resident strain of Klebsiella.

Entities:  

Mesh:

Year:  1998        PMID: 9522290     DOI: 10.1016/s0195-6701(98)90065-2

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  26 in total

Review 1.  Bacterial biofilms: development, dispersal, and therapeutic strategies in the dawn of the postantibiotic era.

Authors:  Maria Kostakioti; Maria Hadjifrangiskou; Scott J Hultgren
Journal:  Cold Spring Harb Perspect Med       Date:  2013-04-01       Impact factor: 6.915

2.  Somatic serogroups, capsular types, and species of fecal Klebsiella in patients with ankylosing spondylitis.

Authors:  P Toivanen; D S Hansen; F Mestre; L Lehtonen; J Vaahtovuo; M Vehma; T Möttönen; R Saario; R Luukkainen; M Nissilä
Journal:  J Clin Microbiol       Date:  1999-09       Impact factor: 5.948

3.  Identification of clinical isolates of indole-positive and indole-negative Klebsiella spp.

Authors:  Maria Silvana Alves; Rubens Clayton da Silva Dias; Angela Christina Dias de Castro; Lee W Riley; Beatriz Meurer Moreira
Journal:  J Clin Microbiol       Date:  2006-08-23       Impact factor: 5.948

Review 4.  Klebsiella oxytoca and Emerging Nosocomial Infections.

Authors:  Nakul Neog; Upasana Phukan; Minakshi Puzari; Mohan Sharma; Pankaj Chetia
Journal:  Curr Microbiol       Date:  2021-03-03       Impact factor: 2.188

5.  A gene, uge, is essential for Klebsiella pneumoniae virulence.

Authors:  Miguel Regué; Beatriz Hita; Nuria Piqué; Luis Izquierdo; Susana Merino; Sandra Fresno; Vicente Javier Benedí; Juan M Tomás
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

6.  Controlling for severity of illness in outcome studies involving infectious diseases: impact of measurement at different time points.

Authors:  Kerri A Thom; Michelle D Shardell; Regina B Osih; Marin L Schweizer; Jon P Furuno; Eli N Perencevich; Jessina C McGregor; Anthony D Harris
Journal:  Infect Control Hosp Epidemiol       Date:  2008-11       Impact factor: 3.254

7.  Recommended test panel for differentiation of Klebsiella species on the basis of a trilateral interlaboratory evaluation of 18 biochemical tests.

Authors:  Dennis S Hansen; Hazel M Aucken; Titi Abiola; Rainer Podschun
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

8.  Community-acquired versus nosocomial Klebsiella pneumoniae bacteremia: clinical features, treatment outcomes, and clinical implication of antimicrobial resistance.

Authors:  Cheol-In Kang; Sung-Han Kim; Ji-Whan Bang; Hong-Bin Kim; Nam-Joong Kim; Eui-Chong Kim; Myoung-don Oh; Kang-Won Choe
Journal:  J Korean Med Sci       Date:  2006-10       Impact factor: 2.153

9.  Klebsiella pneumoniae lipopolysaccharide O typing: revision of prototype strains and O-group distribution among clinical isolates from different sources and countries.

Authors:  D S Hansen; F Mestre; S Alberti; S Hernández-Allés; D Alvarez; A Doménech-Sánchez; J Gil; S Merino; J M Tomás; V J Benedí
Journal:  J Clin Microbiol       Date:  1999-01       Impact factor: 5.948

10.  Utilization of an intracellular bacterial community pathway in Klebsiella pneumoniae urinary tract infection and the effects of FimK on type 1 pilus expression.

Authors:  David A Rosen; Jerome S Pinkner; Jennifer M Jones; Jennifer N Walker; Steven Clegg; Scott J Hultgren
Journal:  Infect Immun       Date:  2008-04-14       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.